AposHealth® (previously AposTherapy®) is a global leader in the identification and treatment of gait-related conditions. The ... AposHealth®’s foot-worn “Apos3” device is FDA-cleared for treating knee osteoarthritis, to help temporarily reduce knee pain and improve lower extremity function during activities of daily living. It is also a non-FDA cleared wellness device which can help patients live well with other gait-related conditions such as chronic low back and hip pain. With a mission to advance global health through the power of movement, AposHealth®’s latest business unit AposIQ, combines innovative technology, data science and over a decade of experience in gait modification to determine the optimal way to adjust patients’ gaits over time. Since 2005, AposHealth® has been making it possible for patients in the US, UK, and Israel, to develop better movement patterns and get back to doing the things they love. It addresses the root cause of the pain by shifting the pressure from the painful area and by re-educating the muscles for a healthier walking pattern, even when not wearing the device. The treatment results in long-lasting improved mobility, high patients satisfaction rate, and economical benefits to payers, providers, and participating practitioners. AposTherapy is adopted by prestigious healthcare organizations and has demonstrated success with 70,000 patients treated worldwide consistently achieving exceptionally high consumer satisfaction scores. AposTherapy is currently available in the UK, US, Israel and Singapore. read more